Review
Open access
Aug 2026
Navigating CAR-T translation in Australia: lessons from an academic program
Adoptive cell therapies utilizing both gene-modified and unmodified immune cells have revolutionized treatments for cancer and infection. Seven Chimeric antigen receptor (CAR) T cell products have been approved as therapies, providing the momentum to expand their clinical benefit to several cancer types. Many novel rec...
Rui Tan, R. Walsh, G. McCowage et al.
· Frontiers in Medicine · 0 citations